Literature DB >> 28608272

CTG18.1 repeat expansion may reduce TCF4 gene expression in corneal endothelial cells of German patients with Fuchs' dystrophy.

Sabine Foja1, Mirjam Luther2, Katrin Hoffmann2, Andreas Rupprecht3, Claudia Gruenauer-Kloevekorn3.   

Abstract

PURPOSE: It was the aim of this investigation to elucidate the functional effects of CTG18.1 trinucleotide repeat expansion and the polymorphism rs613872 in the transcription factor 4 (TCF4) in corneas of patients affected by Fuchs' endothelial corneal dystrophy (FECD).
METHODS: Sixty-one unrelated German patients with FECD and 113 unaffected controls were investigated and genotyped for the CTG18.1 locus by triplet primed PCR (TP-PCR) and the rs613872 polymorphism via Sanger sequencing and by employing genomic DNA from peripheral blood leucocytes. DNA and RNA retrieved from human corneal endothelial explants were examined for alterations in the gene expression of TCF4, ZEB1, E-cadherin, N-cadherin, as well as the CTG18.1 locus.
RESULTS: The CTG18.1 trinucleotide repeat expansion (>50 repeats) was detected in the peripheral blood in 77% of affected FECD patients and 11.5% of the healthy volunteers. Applying the TP-PCR method, the length of CTG18.1 repeat expansions correlates in the blood and corneal cells. We noted that the CTG18.1 trinucleotide repeat expansion was associated with reduced TCF4 and ZEB1 gene expression, especially in the explanted corneal endothelial cells. While E-cadherin gene expression was not detected in any corneal endothelial cells, expression of CDH2 (N-cadherin) was detected in FECD-affected endothelium and in our controls.
CONCLUSIONS: The CTG18.1 repeat expansion may reduce gene expression of TCF4 and ZEB1, suggesting that a mechanism triggering a loss of function may contribute to FECD. The correlation of CTG18.1 repeat expansion from blood and the cornea may represent the first step toward investigating the potential relevance of testing the blood of cornea donors to minimize the risk of transplanting grafts potentially affected with FECD.

Entities:  

Keywords:  CTG18.1 repeat expansion; Fuchs’ dystrophy; Reduced TCF4 expression

Mesh:

Substances:

Year:  2017        PMID: 28608272     DOI: 10.1007/s00417-017-3697-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  48 in total

1.  Trends in the indications for corneal graft surgery in the United Kingdom: 1999 through 2009.

Authors:  Tiarnan D L Keenan; Mark N A Jones; Sally Rushton; Fiona M Carley
Journal:  Arch Ophthalmol       Date:  2012-05

2.  Major progress in Fuchs's corneal dystrophy.

Authors:  Alan F Wright; Baljean Dhillon
Journal:  N Engl J Med       Date:  2010-08-25       Impact factor: 91.245

3.  β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.

Authors:  Ester Sánchez-Tilló; Oriol de Barrios; Laura Siles; Miriam Cuatrecasas; Antoni Castells; Antonio Postigo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-11       Impact factor: 11.205

4.  Transethnic replication of association of CTG18.1 repeat expansion of TCF4 gene with Fuchs' corneal dystrophy in Chinese implies common causal variant.

Authors:  Chao Xing; Xin Gong; Imran Hussain; Chiea-Chuen Khor; Donald T H Tan; Tin Aung; Jodhbir S Mehta; Eranga N Vithana; V Vinod Mootha
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-08       Impact factor: 4.799

5.  Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2).

Authors:  Eranga N Vithana; Patricio Morgan; Periasamy Sundaresan; Neil D Ebenezer; Donald T H Tan; Moin D Mohamed; Seema Anand; Khin O Khine; Divya Venkataraman; Victor H K Yong; Manuel Salto-Tellez; Anandalakshmi Venkatraman; Ke Guo; Boomiraj Hemadevi; Muthiah Srinivasan; Venkatesh Prajna; Myint Khine; Joseph R Casey; Chris F Inglehearn; Tin Aung
Journal:  Nat Genet       Date:  2006-06-11       Impact factor: 38.330

6.  E2-2 protein and Fuchs's corneal dystrophy.

Authors:  Keith H Baratz; Nirubol Tosakulwong; Euijung Ryu; William L Brown; Kari Branham; Wei Chen; Khoa D Tran; Katharina E Schmid-Kubista; John R Heckenlively; Anand Swaroop; Goncalo Abecasis; Kent R Bailey; Albert O Edwards
Journal:  N Engl J Med       Date:  2010-08-25       Impact factor: 91.245

7.  Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing.

Authors:  Mari Sepp; Kaja Kannike; Ave Eesmaa; Mari Urb; Tõnis Timmusk
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

Review 8.  Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized stem cell therapy in corneal endothelial diseases and glaucoma.

Authors:  Wing Yan Yu; Carl Sheridan; Ian Grierson; Sharon Mason; Victoria Kearns; Amy Cheuk Yin Lo; David Wong
Journal:  J Biomed Biotechnol       Date:  2011-12-06

9.  Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation.

Authors:  Marc P Forrest; Adrian J Waite; Enca Martin-Rendon; Derek J Blake
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

10.  Differing roles for TCF4 and COL8A2 in central corneal thickness and fuchs endothelial corneal dystrophy.

Authors:  Robert P Igo; Laura J Kopplin; Peronne Joseph; Barbara Truitt; Jeremy Fondran; David Bardenstein; Anthony J Aldave; Christopher R Croasdale; Marianne O Price; Miriam Rosenwasser; Jonathan H Lass; Sudha K Iyengar
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more
  13 in total

Review 1.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

2.  Association of rs613872 and Trinucleotide Repeat Expansion in the TCF4 Gene of German Patients With Fuchs Endothelial Corneal Dystrophy.

Authors:  Naoki Okumura; Ryousuke Hayashi; Masakazu Nakano; Kei Tashiro; Kengo Yoshii; Ross Aleff; Malinda Butz; Edward W Highsmith; Eric D Wieben; Michael P Fautsch; Keith H Baratz; Yuya Komori; Emi Ueda; Makiko Nakahara; Julia Weller; Theofilos Tourtas; Ursula Schlötzer-Schrehardt; Friedrich Kruse; Noriko Koizumi
Journal:  Cornea       Date:  2019-07       Impact factor: 2.651

3.  Cancer Risk in Patients With Fuchs Endothelial Corneal Dystrophy.

Authors:  Timothy T Xu; Keith H Baratz; Michael P Fautsch; David O Hodge; Michael A Mahr
Journal:  Cornea       Date:  2021-09-27       Impact factor: 3.152

4.  Family Matters: The Nurse's Role in Assessing Family Health History in Ocular Disease.

Authors:  Frances M Peterson-Burch
Journal:  Insight       Date:  2018       Impact factor: 0.878

Review 5.  Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy.

Authors:  Naoki Okumura; Ryousuke Hayashi; Noriko Koizumi
Journal:  Open Ophthalmol J       Date:  2018-07-23

6.  Effect of Trinucleotide Repeat Expansion on the Expression of TCF4 mRNA in Fuchs' Endothelial Corneal Dystrophy.

Authors:  Naoki Okumura; Ryosuke Hayashi; Masakazu Nakano; Kengo Yoshii; Kei Tashiro; Takahiko Sato; Derek J Blake; Ross Aleff; Malinda Butz; Edward W Highsmith; Eric D Wieben; Michael P Fautsch; Keith H Baratz; Yuya Komori; Makiko Nakahara; Theofilos Tourtas; Ursula Schlötzer-Schrehardt; Friedrich Kruse; Noriko Koizumi
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-01       Impact factor: 4.799

Review 7.  REVIEW: Current understanding of the pathogenesis of Fuchs' endothelial corneal dystrophy.

Authors:  Gargi Gouranga Nanda; Debasmita Pankaj Alone
Journal:  Mol Vis       Date:  2019-06-05       Impact factor: 2.367

Review 8.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

9.  The Fuchs corneal dystrophy-associated CTG repeat expansion in the TCF4 gene affects transcription from its alternative promoters.

Authors:  Alex Sirp; Kristian Leite; Jürgen Tuvikene; Kaja Nurm; Mari Sepp; Tõnis Timmusk
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

Review 10.  Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy.

Authors:  Xuerui Liu; Tao Zheng; Chuchu Zhao; Yi Zhang; Hanruo Liu; Liyuan Wang; Ping Liu
Journal:  Eye Vis (Lond)       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.